AK
About
Akihiro Ko is the CEO at Elixirgen Therapeutics.Through his management efforts, he optimized the company’s business development and operations. With the establishment of Elixirgen Scientific, LLC, he assumed the position of President in August 2016. He has been responsible for business operations, marketing, and business development at Elixirgen Scientific. In 2017, he joined Elixirgen Therapeutics as Chief Executive Officer. He earned a Bachelor of Science degree from University of Virginia, where he cultivated his interest in stem cell biology and epigenetics through his research involving bivalent domains in cancer stem cells.
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Akihiro Ko is one of them.
- • 242 investors are based in Baltimore, Maryland, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Baltimore, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Akihiro
Search Investors